|Table of Contents|

Summary of the study on the relationship between breast cancer and thyroid diseases

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 05
Page:
896-900
Research Field:
Publishing date:

Info

Title:
Summary of the study on the relationship between breast cancer and thyroid diseases
Author(s):
WU Dan1QI Zhongwen1FANG Wenyan2ZHAO Cheng2
1.Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;2.The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300000,China.
Keywords:
breast cancerthyroid diseasethyroid hormonesoestrogeniodine
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2021.05.040
Abstract:
Breast cancer is the most common malignant tumor in women.Thyroid disease is also common in women.It is not uncommon to find that patients with breast cancer complicated with thyroid disease in clinical practice.Literature studies have also confirmed that the incidence of thyroid disease in patients with breast cancer is higher than that in normal people.It is considered that both mammary gland and thyroid gland are endocrine organs and are regulated by hypothalamus-pituitary-gland axis,so there may be a certain relationship between them.This article summarizes the relationship between breast cancer and thyroid diseases.

References:

[1]BEATSON GT.Classics in oncology:On the treatment of inoperable cases of carcinoma of the mamma:suggestions for a new method of treatment,with illustrative cases[J].Lancet,1989,2(3803):162-165.
[2]CHIAPPA C,ROVERA F,RAUSEI S,et al.Breast cancer and thyroid diseases:analysis of 867 consecutive cases[J].Journal of Endocrinological Investigation,2017,40(2):179-184.
[3] DOBRINJA C,SCOMERSI S,GIUDICI F,et al.Association between benign thyroid disease and breast cancer:a single center experience[J].BMC Endocr Disord,2019,19(1):104.
[4]HUANG NS,CHEN XX,WEI WJ,et al.Association between breast cancer and thyroid cancer:A study based on 13978 patients with breast cancer[J].Cancer Medicine,2018,7(12):6393-6400.
[5]PRINZI N,BALDINI E,SORRENTI S,et al.Prevalence of breast cancer in thyroid diseases:results of a cross-sectional study of 3921 patients[J].Breast Cancer Research & Treatment,2014,144(3):683-688.
[6]SGAARD M,FARKAS DK,EHRENSTEIN V,et al.Hypothyroidism and hyperthyroidism and breast cancer risk:a nationwide cohort study[J].European Journal of Endocrinology,2016,174(4):409-414.
[7]JISKRA J,LíMANOVá Z,BARKMANOVá J,et al.Autoimmune thyroid diseases in women with breast cancer and colorectal cancer[J].Physiological Research,2004,53(6):693-702.
[8]GOGAS J,KOUSKOS E,TSELENI-BALAFOUTA S,et al.Autoimmune thyroid disease in women with breast carcinoma[J].Eur J Surg Oncol,2001,27(7):626-630.
[9]SHI YL,LI X,RAN L,et al.Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients[J].Oncotarget,2017,8(46):80820-80825.
[10] AN JH,HWANGBO Y,AHN HY,et al.A possible association between thyroid cancer and breast cancer[J].Thyroid:Official Journal of the American Thyroid Association,2015,25(12):1330-1338.
[11]KIM EY,CHANG Y,LEE KH,et al.Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk:A cohort study[J].Int J Cancer,2019,145(12):3257-3266.
[12]HERCBERGS A,MOUSA SA,LEINUNG M,et al.Thyroid hormone in the clinic and breast cancer[J].Horm Cancer,2018,9(3):139-143.
[13]CENGIZ O,BOZKURT B,UNAL B,et al.The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women[J].Journal of Surgical Oncology,2004,87(1):19-25.
[14]CRISTOFANILLI M,YAMAMURA Y,KAU SW,et al.Thyroid hormone and breast carcinoma:Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma[J].Cancer,2005,103(6):1122-1128.
[15]GONZáLEZ-SANCHO JM,FIGUEROA A,LóPEZ-BARAHONA M,et al.Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells[J].Molecular Carcinogenesis,2002,34(1):25-34.
[16]HUANG J,JIN L,JI G,et al.Implication from thyroid function decreasing during chemotherapy in breast cancer patients:chemosensitization role of triiodothyronine[J].BMC Cancer,2013,13(1):334.
[17]田甜,张淑群.甲状腺激素及其受体与乳腺癌的关系[J].现代肿瘤医学,2016,24(9):1483-1486. TIAN T,ZHANG SQ.The relationship between thyroid hormone,thyroid hormone receptors and breast cancer[J].Modern Oncology,2016,24(9):1483-1486.
[18]FIGUEIREDO NB,CESTARI SH,CONDE SJ,et al.Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line[J].The Scientific World Journal,2014(2014):1-7.
[19]CESTARI SH,FIGUEIREDO NB,CONDE SJ,et al.Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors[J].Arq Bras Endocrinol Metabol,2009,53(7):859-864.
[20]TOSOVIC A,BECKER C,BONDESON AG,et al.Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk[J].Int J Cancer,2012,131(9):2126-2133.
[21]BRANDT J,BORGQUIST S,MANJER J.Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups:a malm diet and cancer study[J].Cancer Causes Control,2015,26(8):1093-1104.
[22]KUIJPENS JL,NYKLICTEK I,LEUWMAN MW,et al.Hypothyroidism might be related to breast cancer in postmenopausal women[J].Thyroid,2005,15(11):1253-1259.
[23]GU G,GELSOMINO L,COVINGTON KR,et al.Targeting thyroid hormone receptor beta in triple-negative breast cancer[J].Breast Cancer Research and Treatment,2015,150(3):535-545.
[24]KRESS E,SAMARUT J,PLATEROTI M.Thyroid hormones and the control of cell proliferation or cell differentiation:paradox or duality[J].Molecular & Cellular Endocrinology,2009,313(1/2):36-49.
[25]MARTíNEZ-IGLESIAS O,GARCIA-SILVA S,TENBAUM SP,et al.Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis[J].Cancer Research,2009,69(2):501-509.
[26] PARK JW,ZHAO L,WILLINGHAM M,et al.Oncogenic mutations of thyroid hormone receptor β[J].Oncotarget,2015,6(10):8115-8131.
[27]LóPEZ-FONTANA CM,SASSO CV,MASELLI ME,et al.Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors[J].Oncol Rep,2013,30(4):1651-1660.
[28]DITSCH N,TOTH B,HIMSL I,et al.Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer[J].Histol Histopathol,2013,28(2):227-37.
[29]VILLA NATALIE M,LI N,YEH MW,et al.Serum thyrotropin concentrations are not predictive of aggressive breast cancer biology in euthyroid individuals[J].Endocr Pract,2015,21(9):1040-1045.
[30] KHAN SR,CHAKER L,RUITER R,et al.Thyroid function and cancer risk:The rotterdam study[J].J Clin Endocrinol Metab,2016,101(12):5030-5036.
[31]MOUROUZIS I,TZOVARAS A,ARMONIS B,et al.Are thyroid hormone and tumor cell proliferation in human breast cancers positive for HER2 associated[J].Int J Endocrinol,2015,2015:1-6.
[32]BRANDT J,BORGQUIST S,ALMQUIST M,et al.Thyroid function and survival following breast cancer[J].British Journal of Surgery,2016,103(12):1649-1657.
[33]SZYCHTA P,SZYCHTA W,GESING A,et al.TSH receptor antibodies have predictive value for breast cancer-retrospective analysis[J].Thyroid Research,2013,6(1):8.
[34]HARDEFELDT PJ,ESLICK GD,EDIRIMANNE S.Benign thyroid disease is associated with breast cancer:a meta-analysis[J].Breast Cancer Research & Treatment,2012,133(3):1169-1177.
[35]DRUGARIN D,NEGRU S,KORECK A,et al.The pattern of a T(H)1 cytokine in autoimmune thyroiditis[J].Immunology Letters,2000,71(2):73-77.
[36]CHYAN A,CHEN J,SHUGARD E,et al.Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy[J].Radiation Oncology,2014,9(1):269.
[37]MULLER I,GIANI C,ZHANG L,et al.Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer[J].International Journal of Cancer,2014,134(7):1706-1714.
[38]FARAHATI J,ROGGENBUCK D,GILMAN E,et al.Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer[J].Clin Chem Lab Med,2012,50(4):709-714.
[39]DERWAHL M,NICULA D.Estrogen and its role in thyroid cancer[J].Endocr Relat Cancer,2014,21(5):T273-T283.
[40]FARIA CC,PEIXOTO MS,CARVALHO DP,et al.The emerging role of estrogens in thyroid redox homeostasis and carcinogenesis[J].Oxid Med Cell Longev,2019,2019:1-13.
[41]SANTIN AP,FURLANETTO TW.Role of estrogen in thyroid function and growth regulation[J].Journal of Thyroid Research,2011,2011:1-7.
[42]KANSAKAR E,CHANG YJ,MEHRABI M,et al.Expression of estrogen receptor,progesterone receptor,and vascular endothelial growth factor-A in thyroid cancer[J].American Surgeon,2009,75(9):785-789.
[43]RAJORIA S,SURIANO R,SHANMUGAM A,et al.Metastatic phenotype is regulated by estrogen in thyroid cells[J].Thyroid,2010,20(1):33-41.
[44]ZIMMERMANN MB.Thyroid gland:Iodine deficiency and thyroid nodules[J].Nat Rev Endocrinol,2014,10(251):707-708.
[45]O'KANE SM,MULHERN MS,POURSHAHIDI LK,et al.Micronutrients,iodine status and concentrations of thyroid hormones:a systematic review[J].Nutr Rev,2018,76(6):418-431.
[46]SHI XZ,XUE L,JIN X,et al.Different expression of sodium-iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR)[J].Journal of Endocrinological Investigation,2017,40(1):41-48.
[47]ACEVES C,GARCíA-SOLíS P,ARROYO-HELGUERA O,et al.Antineoplastic effect of iodine in mammary cancer:participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)[J].Molecular Cancer,2009,8(1):33.
[48] ARROYO-HELGUERA O,ROJAS E,DELGADO G,et al.Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells:evidence that 6-iodolactone mediates apoptotic effects[J].Endocrine-Related Cancer,2008,15(4):1003-1011.
[49]韩俊庆,俞新爽,刘奇.甲状腺疾病与乳腺癌的关系[J].实用肿瘤学杂志,2008,22(1):63-65. HAN JQ,YU XS,LIU Q.Relationship between thyroid disease and breast cancer[J].Practical Oncology Journal,2008,22(1):63-65.

Memo

Memo:
天津市科技计划项目(编号:15ZXLCS0020);天津市卫生和计划生育委员会中医中西医结合科研课题资助项目(编号:2015089)
Last Update: 2021-01-29